July 6, 2026 · Form 4 insider transaction
Finley John David bought 335,167 shares of Palisade Bio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 9, 2026.; Includes 1,899 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026. In addition, the amount of securities beneficially owned was reduced by 66 shares due to an administrative error in the total reported in the Form 4 filed February 13, 2026.